Skip to Main Content

Paper Details

Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization.
Exp Eye Res
2
2022
Opticin, VEGF, aflibercept, diabetic retinopathy, human, human recombinant opticin, hyperoxia, mice, murine, oxygen, pre-retinal neovascularization, proliferative, recombinant human opticin, retinal neovascularization, retinopathy of prematurity
Author NameAffiliation
Catey BunceKing's College London
Richard D UnwinUniversity of Manchester
  • 1 - 2

Datasets

Release 1.2